Gene · 84148
Papers2,655
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,655
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting KAT8 alleviates self-RNA-driven skin inflammation by modulating histone H4 lysine 16 acetylation in psoriasis. | Cell Death Differ | 2026 | 40691280 | PubTator, text mining | PubMed |
| Structural Organization of Imidazolium-Based Ionic Liquids and Metal-Organic Frameworks within a Fluorinated Polymer Matrix and Its Influence on the Physical-Chemical Response. | ACS Appl Polym Mater | 2025 | 41573265 | PubTator, text mining | PubMed |
| Homozygous Deletion of the Epigenetic Regulator PHF20 in Individuals With Neurodevelopmental Disorder. | Hum Mutat | 2025 | 41438488 | PubTator, text mining | PubMed |
| Epigenetic activation of CD274/PD-L1 by the MSL complex expands its role beyond dosage compensation. | Front Immunol | 2025 | 41409271 | PubTator, text mining | PubMed |
| Highly Accurate and Fast Prediction of MOF Free Energy via Machine Learning. | J Am Chem Soc | 2025 | 41401044 | PubTator, text mining | PubMed |
| Synthesis of Acid-Base-Resistant 3D MOF-Network with Ligand Containing a Concave Backbone and Convex Binding Sites. | J Org Chem | 2025 | 41365677 | PubTator, text mining | PubMed |
| Mechanistic Understanding of Protein-MOF Integration through Surfactant-Driven Interfacial Design. | bioRxiv | 2025 | 41292977 | PubTator, text mining | PubMed |
| C8orf33 dictates DNA double-strand break repair choice by modulating KAT8-mediated H4K16 acetylation. | Cell Death Dis | 2025 | 41249114 | PubTator, text mining | PubMed |
| MOF-ChemUnity: Literature-Informed Large Language Models for Metal-Organic Framework Research. | J Am Chem Soc | 2025 | 41212798 | PubTator, text mining | PubMed |
| FFLAME: a fragment-to-framework learning approach for MOF potentials. | Digit Discov | 2025 | 41210551 | PubTator, text mining | PubMed |
| Metal-Organic Frameworks as Advanced Gene Delivery Vectors: Mechanisms, Functionalization, and Biomedical Applications. | Int J Nanomedicine | 2025 | 41169751 | PubTator, text mining | PubMed |
| Rationally Trapped Polycrystalline Perovskite in Lanthanide MOF Cages for Ammonia-Mediated Nucleic Acid Intelligent Visualization. | Small | 2025 | 41123979 | PubTator, text mining | PubMed |
| Metal-organic framework-immobilized track-etched membrane with PVC nanofiber mats for carbon dioxide capture. | RSC Adv | 2025 | 41064138 | PubTator, text mining | PubMed |
| MOF modified with a Cu-complex as a novel MOF-based heterogeneous catalyst for the one-pot one-step synthesis of α-aminophosphonates directly from alcohols by a tandem oxidation process. | RSC Adv | 2025 | 41058654 | PubTator, text mining | PubMed |
| 32 examples of LLM applications in materials science and chemistry: towards automation, assistants, agents, and accelerated scientific discovery. | Mach Learn Sci Technol | 2025 | 41050438 | PubTator, text mining | PubMed |
| Synthesis of Magnetically Modified Copper-Based Metal-Organic Frameworks for Cellulose Hydrolysis. | ACS Omega | 2025 | 41048809 | PubTator, text mining | PubMed |
| Hierarchical small molecule inhibition of MYST acetyltransferases. | bioRxiv | 2025 | 41031017 | PubTator, text mining | PubMed |
| Regulation of NSL by TAF4A is critical for genome stability and quiescence of muscle stem cells. | Nat Commun | 2025 | 41028714 | PubTator, text mining | PubMed |
| MOF-Mediated Aloe-Emodin Delivery Enhances Hepatocellular Carcinoma Immunotherapy via Pyroptosis and Immunosuppressant Synergy. | Int J Nanomedicine | 2025 | 41019237 | PubTator, text mining | PubMed |
| Mammalian H4K16ac regulates the spatiotemporal order of genome replication rather than gene expression. | Nucleic Acids Res | 2025 | 40985775 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84148/papers?page=8